Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma

Lignende værker

• Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma
  af: Tang, Xin, et al.
  Udgivet: (2020)
• B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
  af: Tang, Xin, et al.
  Udgivet: (2019)
• B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
  af: Zhang, Zongliang, et al.
  Udgivet: (2020)
• Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
  af: Brown, Christine E., et al.
  Udgivet: (2016)
• Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma
  af: Wang, Yuelong, et al.
  Udgivet: (2020)